Surgical Innovations (GB:SUN) has released an update.
Surgical Innovations Group PLC reported a 9.3% revenue increase in the first half of 2024, with strong growth in SI-branded products and success in OEM sales thanks to resolved supply chain issues. The company is on track with transitioning to EU Medical Device Regulation and has implemented cost reduction strategies, expecting improved margins and profitability in the second half of 2024 and into 2025. Despite some challenges in the UK market, global sales remain robust and new contracts promise additional revenue streams.
For further insights into GB:SUN stock, check out TipRanks’ Stock Analysis page.
